« Home « Kết quả tìm kiếm

Idiopathic pulmonary fibrosis

Tìm thấy 20+ kết quả cho từ khóa "Idiopathic pulmonary fibrosis"

Outcomes for hospitalized patients with idiopathic pulmonary fbrosis treated with antifibrotic medications

tailieu.vn

with idiopathic pulmonary fibrosis treated with antifibrotic medications. Background: Idiopathic Pulmonary Fibrosis is a chronic, progressive interstitial lung disease for which there is no cure.

Efficacy of early antifibrotic treatment for idiopathic pulmonary fbrosis

tailieu.vn

IPF: Idiopathic pulmonary fibrosis. Idiopathic pulmonary fibrosis. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis. A multi- dimensional index and staging system for idiopathic pulmonary fibrosis..

Morbidity and mortality reduction associated with polysomnography testing in idiopathic pulmonary fbrosis: A population-based cohort study

tailieu.vn

Natural history of idiopathic pulmonary fibrosis. Acute exacerbation of idi- opathic pulmonary fibrosis: incidence, risk factors and outcome. Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPAC- ITY): two randomised trials. How common is sleep-disordered breathing in patients with idiopathic pulmonary fibrosis? Sleep Breath.

Longitudinal serological assessment of type VI collagen turnover is related to progression in a real-world cohort of idiopathic pulmonary fbrosis

tailieu.vn

Diagnosis of idiopathic pulmonary fibrosis an official ATS/. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Therapeutic targets in idiopathic pulmonary fibrosis. Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis. Forced vital capacity in idiopathic pulmonary fibrosis - FDA review of pirfenidone and nintedanib. Type VI collagen anchors endothelial basement membranes by interacting with type IV collagen.

Switching antifbrotics in patients with idiopathic pulmonary fbrosis: A multi-center retrospective cohort study

tailieu.vn

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Pirfenidone in patients with idiopathic pulmonary fibrosis. An Open-Label Study of the long-term safety of pirfenidone in patients with idiopathic pulmonary fibrosis (RECAP). Long-term safety and tolerability of nintedanib in patients with idi- opathic pulmonary fibrosis: results from the open-label extension study, INPULSIS-ON.

Impact of high‑fow oxygen therapy during exercise in idiopathic pulmonary fbrosis: A pilot crossover clinical trial

tailieu.vn

Impact of high‑flow oxygen therapy. during exercise in idiopathic pulmonary fibrosis:. Background: Supplemental oxygen delivered with standard oxygen therapy (SOT) improves exercise capacity in patients with idiopathic pulmonary fibrosis (IPF). Although high‑flow nasal cannula oxygen therapy (HFNC) improves oxygenation in other respiratory diseases, its impact on exercise performance has never been evaluated in IPF patients.

Pulmonary fibrosis in dyskeratosis congenita: A case report with a PRISMA-compliant systematic review

tailieu.vn

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis

Development of a nomogram for predicting the presence of combined pulmonary fbrosis and emphysema

tailieu.vn

The presence of emphysema further impairs physiologic function in patients with idiopathic pulmonary fibrosis. Combined pulmonary fibrosis and emphysema characteristics in a Greek cohort. Combined pulmonary fibrosis and emphysema: a retrospective analysis of clinical characteristics, treatment and prognosis. Idiopathic pulmonary fibrosis:. Meta-analysis of gastroesophageal reflux disease and idiopathic pulmonary fibrosis. Telomere shortening in familial and sporadic pulmonary fibrosis.

Immune infltration landscape and immune-marker molecular typing of pulmonary fbrosis with pulmonary hypertension

tailieu.vn

Role of diabetes mellitus and gastro- oesophageal reflux in the aetiology of idiopathic pulmonary fibrosis.. Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis.. Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003.

Prognostic value of radiological fndings indeterminate for UIP pattern and anterior upper lobe honeycomb-like lesion in chronic fbrosing interstitial lung disease associated with MPO-ANCA

tailieu.vn

An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification. of the idiopathic interstitial pneumonias. Incidence of myeloperoxidase anti-neutrophil cytoplasmic antibody positivity and microscopic polyangitis in the course of idiopathic pulmonary fibrosis.. Pulmonary fibrosis associated with ANCA-positive vasculitides. Retro- spective study of 12 cases and review of the literature

Reliability of histopathologic diagnosis of fbrotic interstitial lung disease: An international collaborative standardization project

tailieu.vn

Analysis of the histologic features associated with interobserver variation in idiopathic pulmonary fibrosis.. Hashisako M, Tanaka T, Terasaki Y, et al. Nicholson AG, Addis BJ, Bharucha H, et al. Walsh SLF, Wells AU, Desai SR, et al. Smith ML, Hariri LP, Mino-Kenudson M et al. Andrade J, Schwarz M, Collard HR, et al. Raghu G, Remy-Jardin M, Ryerson CJ, et al. Yagihashi K, Huckleberry J, Colby TV, et al. Idi- opathic pulmonary fibrosis. Takemura T, Akashi T, Kamiya H, et al.

Serum S100 calcium-binding protein A4 as a novel predictive marker of acute exacerbation of interstitial pneumonia after surgery for lung cancer

tailieu.vn

Lung cancer in patients with idiopathic pulmonary fibrosis. Long-term results and predictors of survival after surgical resection of patients with lung cancer and intersti- tial lung disease. Surgical treatment for primary lung cancer combined with idiopathic pulmonary fibrosis. Impact and predictors of acute exac- erbation of interstitial lung diseases after pulmonary resection for lung cancer.

Increased expression of transient receptor potential channels and neurogenic factors associates with cough severity in a guinea pig model

tailieu.vn

Validation of the Cough Quality-of- Life Questionnaire in patients with idiopathic pulmonary fibrosis. TRP functions in the broncho-pulmonary system. Role of reactive oxygen species and TRP channels in the cough reflex. A study of the cough reflex in idiopathic pulmonary fibrosis. A model of the central regulatory system for cough reflex. Sensory regulation of the cough reflex. Identification of the tracheal and laryngeal afferent neurones mediating cough in anaesthetized guinea-pigs.

Interstitial lung disease is a dominant feature in patients with circulating myositis-specifc antibodies

tailieu.vn

High-resolution CT scoring system-based grading scale predicts the clinical outcomes in patients with idiopathic pulmonary fibrosis

Characteristics of patients meeting the new definition of pre-capillary pulmonary hypertension (Nice 2018) in a single Japanese pulmonary hypertension center

tailieu.vn

Haemo- dynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension. Clinical characterization and survival of patients with borderline elevation in pulmonary artery pressure. definition of pulmonary hypertension on the prevalence of pre-capillary pulmonary hypertension. Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis..

Cyclophosphamide for interstitial lung disease-associated acute respiratory failure: Mortality, clinical response and radiological characteristics

tailieu.vn

CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Cyclophosphamide pulse therapy as treatment for severe interstitial lung diseases. Risk factors for mortality and mortality rates in interstitial lung disease patients in the intensive care unit.

High intensity interval training versus moderate intensity continuous training for people with interstitial lung disease: Protocol for a randomised controlled trial

tailieu.vn

Keywords: Interstitial lung diseases, Idiopathic pulmonary fibrosis, Pulmonary Fibrosis, Exercise,, Rehabilitation, High- Intensity interval training, Endurance training.

The effects of inhaling hydrogen gas on macrophage polarization, fbrosis, and lung function in mice with bleomycin-induced lung injury

tailieu.vn

This study was conducted using a well-established mouse model of lung injury and idiopathic pulmonary fibrosis [15, 17]. In summary, lung injury was generated by administrating bleomycin (bleomycin hydrochlo- ride, Nippon Kayaku, Tokyo, Japan) dissolved in saline intratracheally via tracheotomy [17]. The bleomycin causes persistent inflammation pharmacologically in the bronchus and alveoli, eventually resulting in alveo- lar fibrosis.

High flow nasal therapy in perioperative medicine: From operating room to general ward

tailieu.vn

Effects of nasal high flow on ventilation in volunteers, COPD and idiopathic pulmonary fibrosis patients. Pisani L, Fasano L, Corcione N, Comellini V, Musti MA, Brandao M, et al. Change in pulmonary mechanics and the effect on breathing pattern of high flow oxygen therapy in stable hypercapnic COPD. Nasal high flow oxygen therapy in patients with COPD reduces respiratory rate and tissue carbon dioxide while increasing tidal and end-expiratory lung volumes: a randomised crossover trial.

Breast cancer PAM50 signature: Correlation and concordance between RNA-Seq and digital multiplexed gene expression technologies in a triple negative breast cancer series

tailieu.vn

Several studies for both oncologic and non-oncologic diseases have shown a good correlation between gene expression data from RNA-Seq and NanoString nCoun- ter® (R 2 = 0.90 for FFPE samples in idiopathic pulmonary fibrosis) [19]. Particularly in breast cancer, NanoString nCounter® and RNA-Seq using Illumina TruSeq Ribo- Zero-Gold RNA-Seq enable reliable gene expression analysis from degraded FFPE RNA.